Paratek Pharmaceuticals raises $40m in first round
91464
Paratek Pharmaceuticals Inc. said it has closed the first round of a $40 million private financing. The Boston company is engaged in the discovery and commercialization of new therapeutics that treat serious diseases, with a focus on the growing worldwide problem of antibiotic resistance. The funds will be used primarily to advance programs to develop broad spectrum antibiotics, ...
237168
Shares of Nastech Pharmaceutical Co.  Inc. NSTK.O jumped 23 percent before the bell on Monday after  the company said it tied up with Merck & Co. MRK.N to develop  and market Nastech's experimental nasal spray treatment for  obesity.
667096
The biotech's new cancer candidate passes phase 1 trials.
523183
Synta Pharmaceuticals Corp. plans to announce today that it has raised $80 million from a group of private investors, bringing to more than $200 million the amount the Lexington drug developer has raised since 2002.
419672
Expects to raise $60m from shares Network storage firm Compellent Technologies seeks to sell up to $60m of common stock in the company's initial public offering.â¦
716588
President Bush's inaugural committee is seeking to raise more than $40 million, a record.
557284
The retailer raises guidance after an impressive first quarter.
218452
The drug maker said net income rose 6 percent to $926.3 million and it raised its outlook for the year.
587288
Company is trying to raise more than $32 million in a fourth round of funding as it tests its smart-grid appliance with utility companies.
641779
Schering-Plough Corp.  on  Monday reported quarterly earnings far higher than Wall Street  expected, fueled by growing demand for its drugs against  cholesterol, arthritis, allergies and hepatitis C.
627029
Shares of Nastech Pharmaceutical Co.  Inc. jumped as much as 43 percent on Monday after it said it  formed an alliance with Merck & Co. to develop its  appetite-regulating treatment for obesity.
695165
A group of private investors that could include a founder of Biomet Inc. has offered $10.9 billion for the Warsaw, Ind.-based maker of orthopedic products as they seek to capitalize on baby boomers who want to turn back the clock.
43644
Schering-Plough Corp.  said on Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
69397
EDMONTON (CP) - Shares in Biomira Inc. shot up as much as 48 per cent Wednesday after the drug developer said one of its cancer vaccines has won fast-track investigation status from the US Food and Drug Administration.
338024
The company said first-quarter earnings rose to $88 million on strong Spam sales and a recovery in its turkey business.
728893
Shares of Nastech Pharmaceutical Co. Inc. (NSTK.O: Quote, Profile, Research) jumped 23 percent before the bell on Monday after the company said it tied up with Merck &amp; Co.
428440
Impressive earnings drive the medical device maker to a 52-week high.